BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 19762283)

  • 1. Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival.
    Dobrzanski MJ; Rewers-Felkins KA; Quinlin IS; Samad KA; Phillips CA; Robinson W; Dobrzanski DJ; Wright SE
    Clin Immunol; 2009 Dec; 133(3):333-52. PubMed ID: 19762283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate "Natural" and "Inducible" CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer.
    Dobrzanski MJ; Rewers-Felkins KA; Samad KA; Quinlin IS; Phillips CA; Robinson W; Dobrzanski DJ; Wright SE
    Cancer Immunol Immunother; 2012 Jun; 61(6):839-54. PubMed ID: 22083345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion.
    Hoffmann P; Eder R; Boeld TJ; Doser K; Piseshka B; Andreesen R; Edinger M
    Blood; 2006 Dec; 108(13):4260-7. PubMed ID: 16917003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foxp3(high) and Foxp3(low) Treg cells differentially correlate with T helper 1 and natural killer cells in peripheral blood.
    Lee SK; Kim JY; Jang BW; Hur SE; Na BJ; Lee M; Fukui A; Gilman-Sachs A; Kwak-Kim J
    Hum Immunol; 2011 Aug; 72(8):621-6. PubMed ID: 21600259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis patients have reduced resting and increased activated CD4
    Verma ND; Lam AD; Chiu C; Tran GT; Hall BM; Hodgkinson SJ
    Sci Rep; 2021 May; 11(1):10476. PubMed ID: 34006899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.
    Kutukculer N; Azarsiz E; Aksu G; Karaca NE
    Int J Immunopathol Pharmacol; 2016 Jun; 29(2):241-51. PubMed ID: 26684629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells.
    Zhou J; Bashey A; Zhong R; Corringham S; Messer K; Pu M; Ma W; Chut T; Soiffer R; Mitrovich RC; Lowy I; Ball ED
    Biol Blood Marrow Transplant; 2011 May; 17(5):682-92. PubMed ID: 20713164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4
    Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
    Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
    Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
    Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of antigen specific CD4(+)CD25(+)Foxp3(+)T regulatory cells from naïve natural thymic derived T regulatory cells.
    Hall BM; Tran GT; Robinson CM; Hodgkinson SJ
    Int Immunopharmacol; 2015 Oct; 28(2):875-86. PubMed ID: 25882104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of CD4(+)CD25(high) regulatory T cells from tumor infiltrating lymphocytes predominantly induces Th1 type immune response in vivo which inhibits tumor growth in adoptive immunotherapy.
    Xu L; Xu W; Jiang Z; Zhang F; Chu Y; Xiong S
    Cancer Biol Ther; 2009 Jan; 8(1):66-72. PubMed ID: 19029829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective expansion of memory CD4(+) T cells by mitogenic human CD28 generates inflammatory cytokines and regulatory T cells.
    Singh M; Basu S; Camell C; Couturier J; Nudelman RJ; Medina MA; Rodgers JR; Lewis DE
    Eur J Immunol; 2008 Jun; 38(6):1522-32. PubMed ID: 18446791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients.
    Li L; Lao SH; Wu CY
    Tuberculosis (Edinb); 2007 Nov; 87(6):526-34. PubMed ID: 17851131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICOSL-augmented adenoviral-based vaccination induces a bipolar Th17/Th1 T cell response against unglycosylated MUC1 antigen.
    Carrell RK; Stanton RA; Ethier SP; LaRue AC; Soloff AC
    Vaccine; 2018 Oct; 36(42):6262-6269. PubMed ID: 30219366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood.
    Chen X; Subleski JJ; Hamano R; Howard OM; Wiltrout RH; Oppenheim JJ
    Eur J Immunol; 2010 Apr; 40(4):1099-106. PubMed ID: 20127680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens.
    Pathangey LB; McCurry DB; Gendler SJ; Dominguez AL; Gorman JE; Pathangey G; Mihalik LA; Dang Y; Disis ML; Cohen PA
    Oncotarget; 2017 Feb; 8(7):10785-10808. PubMed ID: 27974697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NY-ESO-1-specific circulating CD4+ T cells in ovarian cancer patients are prevalently T(H)1 type cells undetectable in the CD25+ FOXP3+ Treg compartment.
    Redjimi N; Duperrier-Amouriaux K; Raimbaud I; Luescher I; Dojcinovic D; Classe JM; Berton-Rigaud D; Frenel JS; Bourbouloux E; Valmori D; Ayyoub M
    PLoS One; 2011; 6(7):e22845. PubMed ID: 21829534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th1/Th2 balance and CD45-positive T cell subsets in primary nephrotic syndrome.
    Stachowski J; Barth C; Michałkiewicz J; Krynicki T; Jarmoliński T; Runowski D; Lewandowska-Stachowiak M; Zaniew M; Warzywoda A; Bortkiewicz E; Dobosz M; Maciejewski J; Baldamus CA
    Pediatr Nephrol; 2000 Aug; 14(8-9):779-85. PubMed ID: 10955927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
    Singh AK; Horvath KA; Mohiuddin MM
    Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in levels of CD28-/CD8+ suppressor cell precursor and CD45RO+/CD4+ memory T lymphocytes in the peripheral blood of multiple sclerosis patients.
    Crucian B; Dunne P; Friedman H; Ragsdale R; Pross S; Widen R
    Clin Diagn Lab Immunol; 1995 Mar; 2(2):249-52. PubMed ID: 7697540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.